120 related articles for article (PubMed ID: 6097465)
1. Human platelets possess multiple [3H]imipramine binding sites.
Ieni JR; Zukin SR; Van Praag HM
Eur J Pharmacol; 1984 Nov; 106(3):669-72. PubMed ID: 6097465
[TBL] [Abstract][Full Text] [Related]
2. [3H]Imipramine binding and [3H]5HT uptake in human blood platelets: changes after one week chlorimipramine treatment.
Poirier MF; Loo H; Benkelfat C; Sechter D; Zarifian E; Galzin AM; Schoemaker H; Segonzac A; Langer SZ
Eur J Pharmacol; 1984 Nov; 106(3):629-33. PubMed ID: 6097464
[TBL] [Abstract][Full Text] [Related]
3. Solubilization and assay of [3H]imipramine binding sites from human platelets.
Davis A; Morris J; Tang SW
Eur J Pharmacol; 1983 Jan; 86(3-4):353-9. PubMed ID: 6299755
[TBL] [Abstract][Full Text] [Related]
4. 3H-imipramine binding in platelets: influence of varying proportions of intact platelets in membrane preparations on binding.
Friedl W; Propping P; Weck B
Psychopharmacology (Berl); 1983; 80(1):96-9. PubMed ID: 6306712
[TBL] [Abstract][Full Text] [Related]
5. Binding of [3H]imipramine to human platelet membranes with compensation for saturable binding to filters and its implication for binding studies with brain membranes.
Phillips OM; Wood KM; Williams DC
J Neurochem; 1984 Aug; 43(2):479-86. PubMed ID: 6330301
[TBL] [Abstract][Full Text] [Related]
6. Effect of protein concentration on kinetic constants (Kd and Bmax) of 3H-imipramine binding in blood platelets.
Arora RC; Wunnicke V; Meltzer HY
Biol Psychiatry; 1985 Jan; 20(1):116-9. PubMed ID: 2981127
[TBL] [Abstract][Full Text] [Related]
7. [Binding of tritiated imipramine to human platelets. 1 or several binding sites?].
Scotto di Tella AM; Levy C; Lacarelle B; Tissot R
Encephale; 1986; 12(1):13-7. PubMed ID: 3009134
[TBL] [Abstract][Full Text] [Related]
8. Differences between sodium-dependent and desipramine-defined [3H]imipramine binding in intact human platelets.
Hrdina PD
Biol Psychiatry; 1989 Mar; 25(5):576-84. PubMed ID: 2537664
[TBL] [Abstract][Full Text] [Related]
9. Comparison of filtration and equilibrium dialysis methods for [3H]imipramine binding to human platelets.
Lui N; Almon RR; Jusko WJ
Anal Biochem; 1984 May; 139(1):42-57. PubMed ID: 6331229
[TBL] [Abstract][Full Text] [Related]
10. Reduced Vmax of 3H-serotonin uptake but unchanged 3H-imipramine binding in the platelets of untreated hypertensive subjects.
Kamal LA; Raisman R; Meyer P; Langer SZ
Life Sci; 1984 May; 34(21):2083-8. PubMed ID: 6328154
[TBL] [Abstract][Full Text] [Related]
11. High-affinity 3H-imipramine binding sites: a possible state-dependent marker for major depression.
Marazziti D; Perugi G; Deltito J; Lenzi A; Maremmani I; Placidi GF; Cassano GB
Psychiatry Res; 1988 Feb; 23(2):229-37. PubMed ID: 2834766
[TBL] [Abstract][Full Text] [Related]
12. Lack of seasonal variation in platelet [3H]imipramine binding in humans.
Galzin AM; Lôo H; Sechter D; Langer SZ
Biol Psychiatry; 1986 Aug; 21(10):876-82. PubMed ID: 3017462
[TBL] [Abstract][Full Text] [Related]
13. High- and low-affinity [3H]imipramine binding sites on human platelets: separate determination and involvement of sulphur-containing bonds.
Demushkin VP; Fomenko AM; Plyashkevich YG; Shchurin MR; Brusov OS
Eur J Pharmacol; 1987 Aug; 140(2):171-8. PubMed ID: 2822438
[TBL] [Abstract][Full Text] [Related]
14. Partial characterization of solubilized platelet imipramine binding sites using a new probe, [3H]3-cyanoimipramine ([3H]Ro 11-2465).
Davis A; Morris JM; Tang SW
Eur J Pharmacol; 1985 Feb; 109(1):97-104. PubMed ID: 2986992
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of two components of specific [3H]imipramine binding in rat brain.
Hrdina PD
Eur J Pharmacol; 1984 Jul; 102(3-4):481-8. PubMed ID: 6092098
[TBL] [Abstract][Full Text] [Related]
16. Circannual variations in the density of tritiated imipramine binding sites on blood platelets in man.
Egrise D; Desmedt D; Schoutens A; Mendlewicz J
Neuropsychobiology; 1983; 10(2-3):101-2. PubMed ID: 6325993
[TBL] [Abstract][Full Text] [Related]
17. [3H]-imipramine binding sites in fawn-hooded rats.
Murray TF; DeBarrows BR; Prieur DJ; Meyers KM
Neuropharmacology; 1983 Jun; 22(6):781-4. PubMed ID: 6310435
[TBL] [Abstract][Full Text] [Related]
18. Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranes.
Mellerup ET; Plenge P; Nielsen M
Eur J Pharmacol; 1984 Nov; 106(2):411-3. PubMed ID: 6099278
[TBL] [Abstract][Full Text] [Related]
19. Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptine.
Poirier MF; Galzin AM; Loo H; Pimoule C; Segonzac A; Benkelfat C; Sechter D; Zarifian E; Schoemaker H; Langer SZ
Biol Psychiatry; 1987 Mar; 22(3):287-302. PubMed ID: 3028514
[TBL] [Abstract][Full Text] [Related]
20. High affinity 3H-imipramine binding in human platelets: age and sex effects.
Baron M; Kowalik S; Barkai A; Gruen R
Neuropsychobiology; 1984; 11(3):178-80. PubMed ID: 6089031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
